Dolutegravir and lamivudine maintenance therapy in HIV-1 virologically suppressed patients: results of the ANRS 167 trial (LAMIDOL). Joly, Véronique; Burdet, Charles; Landman, Roland; Vigan, Marie; Charpentier, Charlotte; Katlama, Christine; Cabié, André; Benalycherif, Aida; Peytavin, Gilles; Yeni, Patrick; Mentre, France; Argoud, Anne-Laure; Amri, Imane; Descamps, Diane; Yazdanpanah, Yazdan; LAMIDOL Study Group. The Journal of Antimicrobial Chemotherapy. 2019; 74: p.739-745. doi:10.1093/jac/dky467Article
Épidémiologie clinique